Withdrawal is a potent motivator of drug-seeking behavior in human opiate a
ddicts. Paradoxically, opiate withdrawal reduces dopamine release and suppr
esses behavioral responding in several animal models of addiction. These fi
ndings pose critical questions about how a withdrawal state that depresses
dopaminergic and behavioral functioning contributes to drug seeking. This s
tudy addressed this issue by investigating factors that increase behavioral
activity during opiate withdrawal. Initial experiments revealed that the D
-2-like agonists propylnorapomorphine HCl (NPA; 0.05-0.4 mg/kg, i.p.) and q
uinpirole (0.2-0.4 mg/kg, s.c.) each produced strong locomotor activating e
ffects during opiate withdrawal that were not apparent in the absence of wi
thdrawal. Concurrent stereotypy ratings indicated that these effects of NPA
and quinpirole during withdrawal were not an indirect consequence of chang
es in the stereotypy-inducing effects of these drugs. Subsequent experiment
s showed that locomotion was not increased when opiate withdrawal was induc
ed in the presence of the D-1-like agonist SKF 38393 (1.0-8.0 mg/kg, i.p.),
that the locomotor activation produced by NPA during withdrawal could be a
ttenuated by the D-2-like antagonist eticlopride (0.1-0.2 mg/kg, i.p.), and
that locomotor activating effects of NPA could be observed when withdrawal
was induced by extracting the implanted morphine pellets, but not when the
NPA was given after naltrexone antagonism of acute morphine treatment in n
ondependent rats. These findings indicate that opiate withdrawal regulates
the behavioral impact of D-2-like receptor stimulation so that locomotion i
s markedly increased when these receptors are stimulated during periods of
withdrawal. This potentiation may be important for facilitating behavioral
responses during periods of opiate detoxification.